Yan Linlin, Zhang Henghui, Ma Hui, Liu Di, Li Wei, Kang Yulin, Yang Ruifeng, Wang Jianghua, He Gaixia, Xie Xingwang, Wang Hao, Wei Lai, Lu Zuhong, Shao Qixiang, Chen Hongsong
Department of Immunology, and Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, Jiangsu, China.
Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, 100044, China.
Sci Rep. 2015 Dec 9;5:17950. doi: 10.1038/srep17950.
Mutants in the basal core promoter (BCP) and precore (PC) regions of hepatitis B virus (HBV) genome are associated with the progression of chronic hepatitis B (CHB) infection. However, quasispecies characteristics of naturally occurring mutants in those regions in HBeAg-positive CHB patients has not been well described, partly limited by quantitative assay. This study aimed to develop an Ion Torrent deep sequencing assay to determine BCP and PC mutant percentages in HBeAg-positive CHB patients who were treatment naïve and correlate them with different viral and host factors. Our results showed that Ion Torrent deep sequencing could achieve high accuracy (R(2)>0.99) within a dynamic range between 1% and 100%. Twelve hotspots with prevalence of greater than 20% were observed in EnhII/BCP/PC regions. G1719T, T1753V, A1762T and G1764A were genotype C related. BCP A1762T/G1764A double mutants were generally accompanied with PC 1896 wild type or lower PC G1896A mutant percentage. Lower serum HBeAg and HBsAg levels were associated with higher BCP A1762T/G1764A mutant percentages (≥ 50%). ALT levels were higher in patients with PC G1896A mutant percentage greater than 10%. In conclusion, deep sequencing such as Ion Torrent sequencing could accurately quantify HBV mutants for providing clinical relevant information during HBV infection.
乙型肝炎病毒(HBV)基因组的基础核心启动子(BCP)和前核心(PC)区域的突变体与慢性乙型肝炎(CHB)感染的进展相关。然而,HBeAg阳性CHB患者中这些区域天然存在的突变体的准种特征尚未得到充分描述,部分原因是受定量检测的限制。本研究旨在开发一种Ion Torrent深度测序检测方法,以确定未经治疗的HBeAg阳性CHB患者中BCP和PC突变体的百分比,并将它们与不同的病毒和宿主因素相关联。我们的结果表明,Ion Torrent深度测序在1%至100%的动态范围内可实现高精度(R²>0.99)。在EnhII/BCP/PC区域观察到12个患病率大于20%的热点。G1719T、T1753V、A1762T和G1764A与C基因型相关。BCP A1762T/G1764A双突变体通常伴随着PC 1896野生型或较低的PC G1896A突变体百分比。较低的血清HBeAg和HBsAg水平与较高的BCP A1762T/G1764A突变体百分比(≥50%)相关。PC G1896A突变体百分比大于10%的患者ALT水平较高。总之,诸如Ion Torrent测序之类的深度测序可以准确量化HBV突变体,为HBV感染期间提供临床相关信息。